(Q45035883)

8 December 2017

title

A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence (English)

1 reference

8 December 2017

Jack Barkin

1

1 reference

8 December 2017

Jacques Corcos

2

1 reference

8 December 2017

Sidney Radomski

3

1 reference

8 December 2017

Marie-Paule Jammal

4

1 reference

8 December 2017

Paula C Miceli

5

1 reference

8 December 2017

Joseph L Reiz

6

1 reference

8 December 2017

Zoltan Harsanyi

7

1 reference

8 December 2017

Andrew C Darke

8

1 reference

8 December 2017

UROMAX Study Group

9

1 reference

8 December 2017

language of work or name

1 reference

1 July 2004

1 reference

8 December 2017

published in

Clinical Therapeutics

1 reference

8 December 2017

volume

26

1 reference

8 December 2017

issue

7

1 reference

8 December 2017

page(s)

1026-1036

1 reference

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Oxybutynin for detrusor instability with adjuvant salivary stimulant pastilles to improve compliance: results of a multicentre, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Future studies of overactive bladder: the need for standardization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Gender specificity of tolterodine on micturition and the diurnal variation of urine production of the conscious rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

Clinical efficacy of oxybutynin on sensory urgency as compared with that on motor urgency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990174-9

7 January 2021

10.1016/S0149-2918(04)90174-9

Identifiers

DOI

1 reference

8 December 2017

1 reference